| 7723329 |
Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
Hassan Mahmoud Elokdah, Alexander Greenfield, Kevin G. Liu, Geraldine Ruth McFarlane, Cristina Grosanu +4 more |
2010-05-25 |
|
| 7645752 |
Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors |
Yanfang Li, Albert Jean Robichaud, Gavin David Heffernan, Richard Coghlan, Ronald Charles Bernotas |
2010-01-12 |
|
| 7531564 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Iwan Gunawan, Eric Steven Manas, Michael D. Collini, Heather Harris +3 more |
2009-05-12 |
$187,360,000 |
| 7514411 |
Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
Scott Mayer, Paul J. Dollings |
2009-04-07 |
$98,068,000 |
| 7148247 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Iwan Gunawan, Eric Steven Manas, Michael D. Collini, Heather Harris +3 more |
2006-12-12 |
$89,011,000 |
| 7132402 |
Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
Scott Mayer, Paul J. Dollings |
2006-11-07 |
$116,278,000 |
| 7129258 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Iwan Gunawan, Eric Steven Manas, Michael D. Collini |
2006-10-31 |
$65,193,000 |
| 7071185 |
1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
P. Sivaramakrishnan Ramamoorthy |
2006-07-04 |
|
| 7008636 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2006-03-07 |
$92,854,000 |
| 6903238 |
Substituted indenones as estrogenic agents |
Folake O. Adebi, Heather Harris, James Keith, Leo Albert |
2005-06-07 |
$46,013,000 |
| 6794403 |
Substituted benzoxazoles as estrogenic agents |
Michael S. Malamas, Iwan Gunawan, Eric Steven Manas, Michael D. Collini |
2004-09-21 |
$90,653,000 |
| 6765021 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2004-07-20 |
$287,757,000 |
| 6683107 |
Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
Paul J. Dollings, Folake O. Adebayo |
2004-01-27 |
$389,155,000 |
| 6451845 |
Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
Paul J. Dollings, Folake O. Adebayo |
2002-09-17 |
$105,113,000 |
| 6451827 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2002-09-17 |
$105,113,000 |
| 6391897 |
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
Michael S. Malamas, Folake O. Adebayo |
2002-05-21 |
$250,117,000 |
| 6369072 |
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
Michael S. Malamas, Folake O. Adebayo |
2002-04-09 |
$289,926,000 |
| 6362170 |
Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
Folake O. Adebayo |
2002-03-26 |
$291,222,000 |
| 6340670 |
Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
Scott Mayer, Paul J. Dollings |
2002-01-22 |
$213,378,000 |
| 6339064 |
Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
Folake O. Adebayo |
2002-01-15 |
$597,323,000 |
| 6248764 |
Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
Paul J. Dollings, Folake O. Adebayo |
2001-06-19 |
$395,148,000 |
| 6232322 |
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
Michael S. Malamas, Folake O. Adebayo |
2001-05-15 |
$281,573,000 |
| 6214877 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2001-04-10 |
|
| 6103708 |
Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
Paul J. Dollings, Folake O. Adebayo |
2000-08-15 |
$483,340,000 |
